血液フィルター市場 - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00008206
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 206
Buy Now

血液フィルター市場は、2021 年の 4 億 5,226 万米ドルから 2028 年までに 5 億 3,563 万 4,000 米ドルに達すると予測されています。 2021 年から 2028 年までに 4.1% の CAGR で成長すると推定されています。



血液フィルターは、ポリエステルまたはナイロンで作られた織メッシュで構成されたスクリーン型フィルターで、製品バッグの間に配置されます。そして濾過を行う患者。これらのフィルターは、血流に入ると危険となる可能性のあるマクロ凝集体や非血液成分の粒子状物質から患者を保護することを目的としています。これらは、輸血中に微小凝集部位やフィブリン凝集などのマクロ凝集を除去します。濾過には、血液の保存中に形成される白血球、フィブリン、血小板から作られる粒子やマクロ凝集体の捕捉が含まれます。慢性疾患の負担の増加、外傷や事故の急増、輸血処置の数の増加などの要因が血液フィルター市場の成長を推進しています。しかし、製品リコールは市場の成長を妨げます。



戦略的洞察



血液フィルター市場の有利な地域





市場洞察< /h3>

輸血処置件数の増加が血液フィルター市場の成長を促進



輸血処置に必要な安全で適切な血液の利用可能性を向上させることは、各国の国家医療政策とインフラストラクチャーの不可欠な部分であるべきです。都市部でも田舎でも、いつでも輸血の必要性が生じる可能性があります。過去には、血液の利用不能により、健康不良に苦しむ多くの患者が死亡しました。定期的、自発的、無報酬の献血者のための安定した施設を備えることで、安全な血液の十分かつ確実な供給が保証されます。また、これらのドナーの中で血液由来感染症の有病率が最も低いため、最も安全なドナーのグループでもあります。



輸血を必要とする最も一般的な手術には、心臓血管手術、帝王切開手術、および傷害が含まれます。国立心肺血液研究所と国立衛生研究所 (NIH) の推計によると、米国では毎年 500 万人以上が輸血を必要としています。さらに、自然災害や広範囲にわたる災害により、輸血の需要が世界中で増加しています。貧血、赤血球増加症、白血球増加症、白血球減少症、血小板増加症などの血液疾患の発生率の急増も、血液フィルター市場の成長を後押ししています。 WHO によると、サラセミアを患う子供のほとんどは低所得国で生まれており、そこでは輸血へのアクセスが困難であるか、利用できるのは人口のごく一部です。



輸血に使用される血液フィルター手順はポリエステルまたはナイロンで作られた織メッシュです。これらは、製品バッグと患者の間に配置されるスクリーンタイプのフィルターです。これらのフィルターは、血小板、白血球、フィブリンタンパク質などの潜在的に有害なマクロ凝集体や非血液成分の粒子状物質から患者を保護するように設計されています。大多数の先進国では、輸血フィルターは政府または地域ベースのプログラムによって提供されています。したがって、献血と自発的なドナーに適した施設が利用できるようになると、輸血処置の数が増加し、血液充填剤市場の成長が促進されます。



製品ベースの洞察



製品ベース、血液フィルター市場は、40 ミクロンと 70 ミクロン、100 ミクロンと 170 ミクロンなどにさらに分割されます。 100 ミクロンと 170 ミクロンのセグメントは 2021 年に最大の市場シェアを保持し、予測期間中により高い CAGR を記録すると予想されます。



血液フィルター市場、製品別 - 2021 年および 2028 年



素材ベースの洞察



素材に基づいて、血液フィルター市場はポリカーボネート、ポリエステル、 ABS、その他。ポリエステルセグメントは、2021 年に 35.47% の最大の市場シェアを保持し、予測期間中もその優位性を維持すると予想されます。



アプリケーションベースの洞察



アプリケーションに基づいて、血液フィルター市場は血液処理と輸血に分類されます。輸血セグメントは、2021 年に 73.83% の最大の市場シェアを保持し、予測期間中もその優位性を維持すると予想されます。



エンドユーザーベースの洞察



に基づくエンドユーザーに応じて、血液フィルター市場は血液銀行、病院などに分割されます。血液銀行セグメントは、2021 年に 47.38% の最大の市場シェアを保持し、予測期間中もその優位性を維持すると予想されます。



血液フィルター市場で事業を展開しているさまざまな企業は、製品の発売、合併と買収、コラボレーション、製品革新、製品ポートフォリオの拡張により、世界中で事業展開を拡大し、ブランド名を維持し、エンドユーザーからの高まる需要に対応します。



血液フィルター市場 – 製品別





  • 40 ミクロンおよび 70 ミクロン

  • 100 ミクロンおよび 170 ミクロン

  • その他

血液フィルター市場 – 素材別





  • ポリカーボネート

  • ポリエステル

  • ABS

  • その他


血液フィルター市場 - 用途別





  • 血液処理

  • 輸血


血液フィルター市場 - エンド ユーザー別





  • 血液銀行

  • 病院

  • その他


血液フィルター市場 - 別地理





  • 北アメリカ

    • 米国

    • カナダ

    • メキシコ



  • ヨーロッパ

    • フランス

    • ドイツ

    • イタリア

    • イギリス

    • スペイン

    • その他の地域ヨーロッパ



  • アジア太平洋 (APAC)

    • 中国

    • インド

    • 韓国

    • < li>日本
    • オーストラリア

    • その他のアジア太平洋地域



  • 中東およびアフリカ (MEA)

    • 南アフリカ

    • サウジアラビア

    • アラブ首長国連邦

    • 中東およびアフリカのその他の地域



  • 南部および中部アメリカ (SCAM)

    • ブラジル

    • アルゼンチン

    • 南米および中央アメリカのその他の地域




会社概要





  • 旭化成株式会社

  • フレゼニウス カビ AG

  • マコファーマ

  • ヘモネティクス コーポレーション

  • SA からの情報

  • 株式会社カネカ

  • 川澄研究室。 Inc.

  • Sefar AG

  • 山東中宝康医療器具有限公司

  • 南京双衛生物技術有限公司


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is a blood filter?

A blood filter is a screen-type filter composed of woven mesh made from polyester or nylon, and it is placed between the product bag and the patient for performing filtration. These filters are intended to protect patients from macro-aggregates and non-blood component particulate matter that could be hazardous if enter the bloodstream. They remove macro-aggregates such as micro-aggregate sites and fibrin aggregates during a blood transfusion. Filtration involves capturing particles and macro-aggregates made from leucocytes, fibrin, and platelets, formed during blood storage.

What are the driving factors for the blood filter market across the globe?

Key factors that are driving the growth of this market are an increase in the burden of chronic diseases, a surge in cases of trauma and accidents, and a rising number of blood transfusion procedures are expected to boost the market growth for the blood filter over the years.

Which product led the blood filter market?

The 100micron and 170-micron segment dominated the global blood filter market and held the largest revenue share of 56.80% in 2021.

Which material led the blood filter market?

The polyester segment dominated the global blood filter market and held the largest revenue share of 35.47% in 2021.

Which application held the largest share in the blood filter market?

The blood transfusion segment dominated the global blood filter market and accounted for the largest revenue share of 73.83% in 2021

Which end-user held the largest share in the blood filter market?

The blood banks segment dominated the global colon blood filter market and accounted for the largest revenue share of 47.38% in 2021.

Who are the key players in the blood filter market?

The blood filter market majorly consists of players such Asahi Kasei Corporation, Fresenius Kabi AG, Macopharma, Haemonetics Corporation, Infomed SA, KANEKA CORPORATION, Kawasumi laboratories. Inc., Sefar AG, Shandong Zhongbaokang Medical Implements Co., Ltd, Nanjing Shuangwei Biotechnology Co., Ltd. among others.

What is the regional market scenario of the blood filter market?

Global blood filter market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, The US holds the largest size of the market in this region. Nearly 16 million blood components are transfused each year in the U.S. According to the American Cancer Society, more than 1.8 million people are expected to be diagnosed with cancer in 2020. Many of them will need blood, sometimes daily, during their chemotherapy treatment. Blood products are transfused through intravenous tubing with filters. The filters, which typically have pore diameters of 170 to 260 microns, are used to prevent particulate debris from being administered as well. The trapped material promotes bacterial growth, and the American Association of Blood Banks (AABB) recommends not using a filter for more than 4 hours. The government is also experiencing increasing chronic conditions such as acute kidney injury (AKI), multiple organ dysfunction syndromes, or sepsis. Thus, it is expected that rising incidences of chronic diseases are likely to influence the market's growth. Moreover, the rise in transplant procedures across the United States is expected to increase the blood transfer procedures that require collection units such as tubes, bags, and others. According to the Red Cross Blood Center, 4.5 million Americans require blood transfusion annually.

The List of Companies - Blood Filter Market

  1. Asahi Kasei Corporation
  2. Fresenius Kabi AG
  3. Macopharma
  4. Haemonetics Corporation
  5. Infomed SA
  6. KANEKA CORPORATION
  7. Kawasumi laboratories. Inc.
  8. Sefar AG
  9. Shandong Zhongbaokang Medical Implements Co., Ltd.
  10. Nanjing Shuangwei Biotechnology Co., Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports